Encephalopathy in Cirrhosis: Prevention and Management
- PMID: 35677508
- PMCID: PMC9168742
- DOI: 10.1016/j.jceh.2021.12.007
Encephalopathy in Cirrhosis: Prevention and Management
Abstract
Hepatic encephalopathy (HE) is a major neuropsychiatric complication of cirrhosis. The clinical manifestations of HE ranges from mild confusion, disorientation to altered behaviour and coma in advanced stages. HE is an important cause of recurrent admissions in liver cirrhosis patients. HE is the most common cause of altered mentation in a patient of liver cirrhosis. Lactulose and rifaximin are approved treatment options for the treatment of HE. In patients who have localised neurological signs or are not improving with lactulose and rifaximin should be investigated for other causes of altered sensorium.
Keywords: ALF, Acute Liver Failure; AMS, altered mental state; BCAA, Branched-chain Amino Acids; BRTO, balloon-occluded retrograde transvenous occlusion; CARTO, coil-assisted retrograde transvenous occlusion; FMT; HE, Hepatic encephalopathy; LOLA; OP, Ornithine phenylacetate; PARTO, plug-assisted retrograde transvenous occlusion; SIP, Sickness Impact Profile; cirrhosis; hepatic encephalopathy; lactulose; prevention; probiotics; rifaximin; treatment.
© 2021 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.
Figures
Similar articles
-
Management of hepatic encephalopathy in the hospital.Mayo Clin Proc. 2014 Feb;89(2):241-53. doi: 10.1016/j.mayocp.2013.11.009. Epub 2014 Jan 8. Mayo Clin Proc. 2014. PMID: 24411831 Free PMC article. Review.
-
Combined Balloon-, Plug- and Coil-assisted Retrograde Transvenous Obliteration of Multiple Portosystemic Shunts to Treat Recurrent Hepatic Encephalopathy: A Case Report.J Clin Exp Hepatol. 2020 Jul-Aug;10(4):402-406. doi: 10.1016/j.jceh.2019.12.002. Epub 2019 Dec 26. J Clin Exp Hepatol. 2020. PMID: 32655241 Free PMC article.
-
Retrograde Transvenous Obliteration (RTO): A New Treatment Option for Hepatic Encephalopathy.Dig Dis Sci. 2020 Sep;65(9):2483-2491. doi: 10.1007/s10620-020-06050-7. Epub 2020 Jan 31. Dig Dis Sci. 2020. PMID: 32002756 Review.
-
Results of Portosystemic Shunt Embolization in Selected Patients with Cirrhosis and Recurrent Hepatic Encephalopathy.J Clin Exp Hepatol. 2017 Dec;7(4):300-304. doi: 10.1016/j.jceh.2017.03.012. Epub 2017 Apr 14. J Clin Exp Hepatol. 2017. PMID: 29234193 Free PMC article.
-
Overt Hepatic Encephalopathy: Current Pharmacologic Treatments and Improving Clinical Outcomes.Am J Med. 2021 Nov;134(11):1330-1338. doi: 10.1016/j.amjmed.2021.06.007. Epub 2021 Jul 7. Am J Med. 2021. PMID: 34242619 Review.
Cited by
-
Management of Portal Hypertension.J Clin Exp Hepatol. 2022 Jul-Aug;12(4):1184-1199. doi: 10.1016/j.jceh.2022.03.002. Epub 2022 Mar 21. J Clin Exp Hepatol. 2022. PMID: 35814519 Free PMC article. Review.
-
The Role of Vitamin D Deficiency in Hepatic Encephalopathy: A Review of Pathophysiology, Clinical Outcomes, and Therapeutic Potential.Nutrients. 2024 Nov 23;16(23):4007. doi: 10.3390/nu16234007. Nutrients. 2024. PMID: 39683402 Free PMC article. Review.
References
-
- Ferenci P., Lockwood A., Mullen K., et al. Hepatic encephalopathy—definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology. 2002;35:716–721. - PubMed
-
- Amodio P., Del Piccolo F., Pettenò E., et al. Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients. J Hepatol. 2001;35:37–45. - PubMed
-
- Tapper E.B., Halbert B., Mellinger J. Rates of and reasons for hospital readmissions in patients with cirrhosis: a multistate population-based cohort study. Clin Gastroenterol Hepatol. 2016;14:1181–1188.e2. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous